ASSA ABLOY acquires 3millID and Third Millennium in the US and UK
STOCKHOLM, Jan. 8, 2025 /PRNewswire/ — ASSA ABLOY has signed an agreement to acquire 3millID Corporation and Third Millennium Systems…
Brand Post
H’ART Museum and Aegon announce partnership
The Hague/Amsterdam – January 8, 2025 – The H’ART Museum, a renowned art institution based in Amsterdam, and Aegon Ltd,…
Industry leaders define deliverable benefits and digital transformation best practices in latest season of video series
Executive interviews feature innovators and visionaries explaining the critical role that digital technologies play in sustainability, growth, and employee empowerment…
Seeing Machines to showcase world-leading interior sensing solutions at CES 2025
CANBERRA, Australia, Jan. 8, 2025 /PRNewswire/ — Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered…
Retail’s New Revenue Frontier: SOLUM Showcases AI-Enhanced Display Solution for In-Store Advertising
LAS VEGAS, Jan. 8, 2025 /PRNewswire/ — As retailers seek new revenue streams, in-store digital displays are emerging as powerful advertising…
Stonewall Kitchen Announces New January 2025 Product Launch
Salad dressings, cheese toppers and stuffed peppers bring bold flavors to the kitchen, while new fresh fragrances and collections adds…
Nokia and stc Group set Middle East record with 1Tbps data center connectivity across 850km network
Press Release Nokia and stc Group set Middle East record with 1Tbps data center connectivity across 850km network Nokia and…
Shell fourth quarter 2024 update note
The following is an update to the fourth quarter 2024 outlook and gives an overview of our current expectations for…
Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders
Angelini Ventures co-leads alongside Invivo Partners with participation from Innovestor’s Life Science Fund and other existing investors Financing will support…
Appointment of an advisor to implement changes in the operating and development portfolio
Having assessed the situation on its core markets, the fit of the company’s near-term development portfolio and the existing operating…
Basilea provides portfolio update and outlook
Allschwil, Switzerland, January 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…
Roche purchases shares in tender offer for Poseida Therapeutics, Inc.
Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Blue Giant…
↑